FOXC1 and neoplasm: The addition of both stromal FOXC1 and tumor pERK1‐2 to NCCN‐IPI significantly improved C‐index than NCCN‐IPI alone in the prediction of time to death, (0.801 vs. 0.764, p = 0.030).